The world of addiction treatment has been revolutionized by a new therapy, Mindfulness-Oriented Recovery Enhancement (MORE), which offers a promising solution to the opioid crisis. This innovative approach, developed by Dr. Eric Garland, combines mindfulness techniques with cognitive reappraisal and savoring practices to address addiction, emotional distress, and chronic pain simultaneously. The results of a recent economic evaluation are nothing short of remarkable, with MORE providing a staggering $12 in cost savings for every dollar spent. This therapy not only reduces opioid misuse but also has the potential to save lives and significantly reduce societal costs associated with the opioid epidemic.
Unlocking the Power of the Mind
MORE's unique approach lies in its ability to teach individuals to regulate cravings and pain through mindfulness, manage stress and emotions through cognitive reappraisal, and reconnect with natural rewards through savoring techniques. This holistic approach targets the root causes of opioid misuse, offering a fresh perspective on addiction treatment. Dr. Garland's research highlights how opioid addiction diminishes the brain's capacity for natural pleasure, leading to increased drug cravings. MORE aims to restore this vital function, reducing cravings and preventing further misuse.
Economic Impact and Clinical Success
The economic analysis of MORE's impact is eye-opening. With a benefit-to-cost ratio of 12-to-1, it outperforms several other addiction treatment approaches, including residential and intensive outpatient treatments. The lifetime cost savings per patient are estimated at a staggering $324,489. This therapy not only improves patient outcomes but also reduces the burden on healthcare systems and society as a whole. The researchers attribute these economic benefits to reductions in healthcare utilization, criminal justice involvement, lost productivity, and overdose mortality associated with opioid misuse.
Broader Implications and Future Potential
The success of MORE extends beyond its clinical and economic impact. With over 16 randomized clinical trials involving more than 2,500 participants and training provided to over 1,200 clinicians, MORE has established itself as a reliable and effective therapy. However, its true potential lies in its widespread integration into healthcare systems. Dr. Garland envisions MORE becoming a standard part of addiction treatment, with the hope of intervening early in primary care settings to prevent opioid misuse from progressing to severe addiction. The therapy's scalability and cost-effectiveness make it an attractive solution for healthcare organizations, insurers, and policymakers seeking to address the opioid crisis.
A New Hope for Addiction Treatment
In my opinion, the development of MORE represents a significant advancement in the field of addiction treatment. By combining neuroscience-informed techniques with mindfulness practices, this therapy offers a holistic and effective approach to addressing opioid misuse. The economic evaluation highlights the potential for MORE to not only improve patient outcomes but also reduce the societal burden of the opioid crisis. As we continue to navigate the challenges of addiction, therapies like MORE offer a glimmer of hope and a path towards a healthier and more resilient society.
